262372-11-2

Upstream product

• 93-97-0 benzoic acid anhydride 
• 262372-08-7 (1S,2S,3R,5R)-3-benzoyl-2-benzoylmethyl-1,5-di(tert-butyldimethylsilyloxy)cyclohexane 
• 262372-09-8 (1S,2S,3R,5S)-3-benzoyl-2-benzoylmethyl-5-(tert-butyldimethylsilyloxy)cyclohexanol 

Downstream Products

• 262372-14-5 C₂₆H₂₂ClN₅O₄ 
• 262372-15-6 9-[(1R,4S,5R)-5-benzoyl-4-benzoylmethyl-2-cyclohexenyl]guanine 
• 262372-13-4 9-[(1R,4S,5R)-5-benzoyl-4-benzoylmethyl-2-cyclohexenyl]adenine 
• 262372-04-3 (1R,4S,5R)-9-(5-hydroxy-4-hydroxymethyl-2-cyclohexen-1-yl)guanine 
• 262372-07-6 (1S,4S,5R)-5-benzoyl-4-benzoylmethylcyclohex-2-en-1-ol 
• 262372-12-3 (4S,5R)-5-benzoyl-4-benzoylmethylcyclohex-2-en-1-one 

Relevant academic research and scientific papers

(D)- and (L)-cyclohexenyl-G, a new class of antiviral agents: Synthesis, conformational analysis, molecular modeling, and biological activity

(D)- and (L)-cyclohexeneyl-G were synthesized enantioselectively starting from (R)-carvone. Both show potent and selective anti-herpesvirus activity (HSV-1, HSV-2, VZV, CMV). Molecular modeling demonstrates that both isomers are bound in the active site o

The cyclohexene ring system as a furanose mimic: Synthesis and antiviral activity of both enantiomers of cyclohexenylguanine

Both enantiomers of cyclohexenylguanine were synthesized in a stereospecific way starting from the same starting material: R-(-)-carvone. Both compounds showed potent and selective anti-herpesvirus activity (HSV-1, HSV-2, VZV, CMV). The binding of both cy